FDA
Empagliflozin
The FDA lists this product in 17 strengths and forms.
Composition
- Active ingredients
- EMPAGLIFLOZIN 10MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EMPAGLIFLOZIN 10MG · TabletANDA212371-002 · Tentative approval
- EMPAGLIFLOZIN 2.5MG · TabletANDA212371-003 · Tentative approval
- EMPAGLIFLOZIN 25MG · TabletANDA212138-002 · Discontinued
- EMPAGLIFLOZIN 10MG · TabletANDA212138-001 · Discontinued
- EMPAGLIFLOZIN 25MG · TabletANDA212421-002 · Tentative approval
- EMPAGLIFLOZIN 10MG · TabletANDA212421-001 · Tentative approval
- EMPAGLIFLOZIN 10MG · TabletANDA212365-001 · Tentative approval
- EMPAGLIFLOZIN 25MG · TabletANDA212365-002 · Tentative approval
- EMPAGLIFLOZIN 25MG · TabletANDA212382-002 · Tentative approval
- EMPAGLIFLOZIN 10MG · TabletThis page
- EMPAGLIFLOZIN 10MG · TabletANDA212322-002 · Tentative approval
- EMPAGLIFLOZIN 25MG · TabletANDA212322-003 · Tentative approval
- EMPAGLIFLOZIN 2.5MG · Tablet
At a glance
- Brand name
- Empagliflozin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Alkem Labs LTD
- Status
- Tentative approval
- FDA approval
- 28 Sept 2022
- Application
- ANDA212382-001